Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T40.5X5DBillable
Adverse effect of cocaine, subsequent encounter
- T40.5X5SBillable
Adverse effect of cocaine, sequela
- T40.5X6ABillable
Underdosing of cocaine, initial encounter
- T40.5X6DBillable
Underdosing of cocaine, subsequent encounter
- T40.5X6SBillable
Underdosing of cocaine, sequela
- T40.605ABillable
Adverse effect of unspecified narcotics, initial encounter
- T40.605DBillable
Adverse effect of unspecified narcotics, subsequent encounter
- T40.605SBillable
Adverse effect of unspecified narcotics, sequela
- T40.606ABillable
Underdosing of unspecified narcotics, initial encounter
- T40.606DBillable
Underdosing of unspecified narcotics, subsequent encounter
- T40.606SBillable
Underdosing of unspecified narcotics, sequela
- T40.695ABillable
Adverse effect of other narcotics, initial encounter
- T40.695DBillable
Adverse effect of other narcotics, subsequent encounter
- T40.695SBillable
Adverse effect of other narcotics, sequela
- T40.696ABillable
Underdosing of other narcotics, initial encounter
- T40.696DBillable
Underdosing of other narcotics, subsequent encounter
- T40.696SBillable
Underdosing of other narcotics, sequela
- T40.715ABillable
Adverse effect of cannabis, initial encounter
- T40.715DBillable
Adverse effect of cannabis, subsequent encounter
- T40.715SBillable
Adverse effect of cannabis, sequela
- T40.716ABillable
Underdosing of cannabis, initial encounter
- T40.716DBillable
Underdosing of cannabis, subsequent encounter
- T40.716SBillable
Underdosing of cannabis, sequela
- T40.725ABillable
Adverse effect of synthetic cannabinoids, initial encounter
- T40.725DBillable
Adverse effect of synthetic cannabinoids, subsequent encounter
- T40.725SBillable
Adverse effect of synthetic cannabinoids, sequela
- T40.726ABillable
Underdosing of synthetic cannabinoids, initial encounter
- T40.726DBillable
Underdosing of synthetic cannabinoids, subsequent encounter
- T40.726SBillable
Underdosing of synthetic cannabinoids, sequela
- T40.905ABillable
Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
- T40.905DBillable
Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
- T40.905SBillable
Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
- T40.906ABillable
Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter
- T40.906DBillable
Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter
- T40.906SBillable
Underdosing of unspecified psychodysleptics [hallucinogens], sequela
- T40.995ABillable
Adverse effect of other psychodysleptics [hallucinogens], initial encounter
- T40.995DBillable
Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
- T40.995SBillable
Adverse effect of other psychodysleptics [hallucinogens], sequela
- T40.996ABillable
Underdosing of other psychodysleptics [hallucinogens], initial encounter
- T40.996DBillable
Underdosing of other psychodysleptics [hallucinogens], subsequent encounter
- T40.996SBillable
Underdosing of other psychodysleptics [hallucinogens], sequela
- T41.0X5ABillable
Adverse effect of inhaled anesthetics, initial encounter
- T41.0X5DBillable
Adverse effect of inhaled anesthetics, subsequent encounter
- T41.0X5SBillable
Adverse effect of inhaled anesthetics, sequela
- T41.0X6ABillable
Underdosing of inhaled anesthetics, initial encounter
- T41.0X6DBillable
Underdosing of inhaled anesthetics, subsequent encounter
- T41.0X6SBillable
Underdosing of inhaled anesthetics, sequela
- T41.1X5ABillable
Adverse effect of intravenous anesthetics, initial encounter
- T41.1X5DBillable
Adverse effect of intravenous anesthetics, subsequent encounter
- T41.1X5SBillable
Adverse effect of intravenous anesthetics, sequela
- T41.1X6ABillable
Underdosing of intravenous anesthetics, initial encounter
- T41.1X6DBillable
Underdosing of intravenous anesthetics, subsequent encounter
- T41.1X6SBillable
Underdosing of intravenous anesthetics, sequela
- T41.205ABillable
Adverse effect of unspecified general anesthetics, initial encounter
- T41.205DBillable
Adverse effect of unspecified general anesthetics, subsequent encounter
- T41.205SBillable
Adverse effect of unspecified general anesthetics, sequela
- T41.206ABillable
Underdosing of unspecified general anesthetics, initial encounter
- T41.206DBillable
Underdosing of unspecified general anesthetics, subsequent encounter
- T41.206SBillable
Underdosing of unspecified general anesthetics, sequela
- T41.295ABillable
Adverse effect of other general anesthetics, initial encounter
- T41.295DBillable
Adverse effect of other general anesthetics, subsequent encounter
- T41.295SBillable
Adverse effect of other general anesthetics, sequela
- T41.296ABillable
Underdosing of other general anesthetics, initial encounter
- T41.296DBillable
Underdosing of other general anesthetics, subsequent encounter
- T41.296SBillable
Underdosing of other general anesthetics, sequela
- T41.3X5ABillable
Adverse effect of local anesthetics, initial encounter
- T41.3X5DBillable
Adverse effect of local anesthetics, subsequent encounter
- T41.3X5SBillable
Adverse effect of local anesthetics, sequela
- T41.3X6ABillable
Underdosing of local anesthetics, initial encounter
- T41.3X6DBillable
Underdosing of local anesthetics, subsequent encounter
- T41.3X6SBillable
Underdosing of local anesthetics, sequela
- T41.45XABillable
Adverse effect of unspecified anesthetic, initial encounter
- T41.45XDBillable
Adverse effect of unspecified anesthetic, subsequent encounter
- T41.45XSBillable
Adverse effect of unspecified anesthetic, sequela
- T41.46XABillable
Underdosing of unspecified anesthetics, initial encounter
- T41.46XDBillable
Underdosing of unspecified anesthetics, subsequent encounter
- T41.46XSBillable
Underdosing of unspecified anesthetics, sequela
- T41.5X5ABillable
Adverse effect of therapeutic gases, initial encounter
- T41.5X5DBillable
Adverse effect of therapeutic gases, subsequent encounter
- T41.5X5SBillable
Adverse effect of therapeutic gases, sequela
- T41.5X6ABillable
Underdosing of therapeutic gases, initial encounter
- T41.5X6DBillable
Underdosing of therapeutic gases, subsequent encounter
- T41.5X6SBillable
Underdosing of therapeutic gases, sequela
- T42.0X5ABillable
Adverse effect of hydantoin derivatives, initial encounter
- T42.0X5DBillable
Adverse effect of hydantoin derivatives, subsequent encounter
- T42.0X5SBillable
Adverse effect of hydantoin derivatives, sequela
- T42.0X6ABillable
Underdosing of hydantoin derivatives, initial encounter
- T42.0X6DBillable
Underdosing of hydantoin derivatives, subsequent encounter
- T42.0X6SBillable
Underdosing of hydantoin derivatives, sequela
- T42.1X5ABillable
Adverse effect of iminostilbenes, initial encounter
- T42.1X5DBillable
Adverse effect of iminostilbenes, subsequent encounter
- T42.1X5SBillable
Adverse effect of iminostilbenes, sequela
- T42.1X6ABillable
Underdosing of iminostilbenes, initial encounter
- T42.1X6DBillable
Underdosing of iminostilbenes, subsequent encounter
- T42.1X6SBillable
Underdosing of iminostilbenes, sequela
- T42.2X5ABillable
Adverse effect of succinimides and oxazolidinediones, initial encounter
- T42.2X5DBillable
Adverse effect of succinimides and oxazolidinediones, subsequent encounter
- T42.2X5SBillable
Adverse effect of succinimides and oxazolidinediones, sequela
- T42.2X6ABillable
Underdosing of succinimides and oxazolidinediones, initial encounter
- T42.2X6DBillable
Underdosing of succinimides and oxazolidinediones, subsequent encounter
